ImmunoSensation - the immune sensory system

Back
Nuklearmedizin. 2020 Apr 7.

Textural features in FGD-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and Ipililumab.

Dittrich D, Pyka T, Scheidhauer K, Lütje S, Essler M, Bundschuh RA

 Recently, textural parameters assessed in FDG-PET/CT as surrogate marker for tumor heterogeneity have been shown to provide prognostic power. Therefore, we investigated the use of such parameters in FDG-PET/CT examinations before the start of immunotherapy with vemurafenib or ipilimumab in patients with malignant melanoma.

PMID: 32259852